AbbVie is a global, research-based biopharmaceutical company which combines the focus of a leading-edge biotech with the expertise and structure of a long-established pharmaceutical leader.
Delayed Appropriate Therapy (DAT) in Serious Gram-Negative Infections: A Cause of Increased Morbidity, Length of Stay (LOS), and Hospital Costs
For information about Avycaz please click below:
For more information about Teflaro please click below:
Virtual Drop In:
Friday, October 16, 2020
Access the virtual drop in